In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient costs compared to a plan working its way through Congress to let Medicare negotiate prescription drug prices.
